AND TRANSITION SERVICES AGREEMENT between SANOFITermination, Rights Reversion and Transition Services Agreement • May 3rd, 2017 • Vivus Inc • Pharmaceutical preparations • New York
This TERMINATION, RIGHTS REVERSION AND TRANSITION SERVICES AGREEMENT (this “Agreement”) is made as of February 28, 2017 (the “Execution Date”), by and between Sanofi, a French corporation having its registered office at 54 rue la Boétie, 75008, Paris, France (“Sanofi”) and VIVUS, Inc., a Delaware corporation with its principal office at 900 E. Hamilton Avenue, Suite 550, Campbell, California, 95008, United States of America (“Vivus”). Sanofi and Vivus are each referred to individually as a “Party” and together as the “Parties.”
